MNG
WST icon

Manning & Napier Group’s West Pharmaceutical WST Stock Holding History

Manning & Napier Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-53,167
Closed -$15.1M – 286
2020
Q4 		$15.1M Sell
53,167
-79
-0.1% -$22.2K 0.14% 142
2020
Q3 		$14.6M Sell
53,246
-7,179
-12% -$1.9M 0.15% 124
2020
Q2 		$13.7M Sell
60,425
-850
-1% -$167K 0.15% 124
2020
Q1 		$9.33M Buy
+61,275
New +$9.43M 0.11% 134

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manning & Napier Group's WST Position: Q1 2021 in Review

Manning & Napier Group sold out of West Pharmaceutical (WST) in Q1 2021, closing a stake of 53,167 shares — an estimated $15.1M sold.

Manning & Napier Group first reported a position in WST in Q1 2020 and held it in 4 quarters. The position peaked at $15.1M in Q4 2020. 590 funds tracked by Wall St. Rank hold WST as of Q1 2021.

  • Manning & Napier Group reported no remaining West Pharmaceutical position as of Q1 2021 after selling out during the quarter.
  • Manning & Napier Group sold 53,167 West Pharmaceutical shares in Q1 2021, an estimated $15.1M.
  • Manning & Napier Group first reported a position in West Pharmaceutical in Q1 2020 and held it in 4 quarters.
  • Manning & Napier Group's West Pharmaceutical position peaked at $15.1M in Q4 2020.
  • 590 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2021.

Based on Manning & Napier Group's 13F filing for Q1 2021, filed 28 Apr 2021.